Summary of Purpose
To test whether treatment with tirilazad would reduce ischemic symptoms from vasospasm and improve overall outcome in patients with ruptured aneurysms.Read More →
The following dates are available for this trial. Trial information last updated on 6 April 2001.
|Start Date||First Received||1st Completion||Completion||Verification||Results|
Prospective randomized, double-blind, vehicle-controlled trial of 1023 patients at 41 neurosurgical centers in Europe, Australia, and New Zealand.